Apr. 24, 2024 — People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a new study.

In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...

Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...

New research shows sotagliflozin is the only drug in its class to demonstrate these results. Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes ...